[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q3_USD":9727000.0,"PaymentsToAcquireInvestments_3_Q3_USD":54156000.0,"PaymentsToAcquireEquityMethodInvestments_3_Q3_USD":0.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":12000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToNoncontrollingInterest_3_Q3_USD":0.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToNoncontrollingInterest_1_Q3_USD":0.0,"OtherAssetsNoncurrent_0_Q3_USD":0.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":3000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":2174000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":2355000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":386000.0,"OperatingIncomeLoss_3_Q3_USD":-52726000.0,"OperatingIncomeLoss_1_Q3_USD":-18408000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":751000.0,"OperatingExpenses_3_Q3_USD":60508000.0,"NumberOfOperatingSegments_3_Q3_numberOfSegments":1.0,"NonoperatingIncomeExpense_3_Q3_USD":-2200000.0,"NonoperatingIncomeExpense_1_Q3_USD":-750000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-66491000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-24245000.0,"NetIncomeLoss_3_Q3_USD":-54926000.0,"NetIncomeLoss_1_Q3_USD":-19158000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-47926000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-4557000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":78115000.0,"LiabilitiesCurrent_0_Q3_USD":10113000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":165596000.0,"OperatingExpenses_1_Q3_USD":21748000.0,"Liabilities_0_Q3_USD":35456000.0,"PreferredStockAccretionOfRedemptionDiscount_1_Q3_USD":0.0,"PreferredStockDividendsAndOtherAdjustments_3_Q3_USD":11565000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":97174253.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":101286351.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":2002000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":44736000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":214000.0,"StockholdersEquity_0_Q3_USD":130140000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":4.19,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q3_USD":3.7,"ShareBasedCompensation_3_Q3_USD":4993000.0,"Revenues_3_Q3_USD":7782000.0,"Revenues_1_Q3_USD":3340000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1112452000.0,"PreferredStockDividendsAndOtherAdjustments_1_Q3_USD":5087000.0,"RestructuringReserveAccrualAdjustment1_3_Q3_USD":0.0,"RestructuringCharges_1_Q3_USD":0.0,"ResearchAndDevelopmentExpense_3_Q3_USD":45065000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":16299000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":6352000.0,"ProceedsFromStockPlans_3_Q3_USD":461000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":2225000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_3_Q3_USD":50350000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":75429000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":3466000.0,"PreferredStockSharesOutstanding_0_Q3_shares":1164000.0,"PreferredStockSharesIssued_0_Q3_shares":1164000.0,"PreferredStockIncludingAdditionalPaidInCapitalNetOfDiscount_0_Q3_USD":160973000.0,"RestructuringCharges_3_Q3_USD":0.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":101286351.0,"InvestmentIncomeInterest_3_Q3_USD":97000.0,"InterestExpense_3_Q3_USD":2297000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-19189000.0,"CommonStockValue_0_Q3_USD":1065710000.0,"CommonStockSharesOutstanding_0_Q3_shares":110264915.0,"CommonStockSharesIssued_0_Q3_shares":110264915.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":25632000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":77883000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":151900000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":77883000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q3_USD":5105000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3_Q3_USD":1679000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q3_USD":30534000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":43520000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-54942000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":43500000.0,"Assets_0_Q3_USD":165596000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":34300000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":4993000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":1615000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":1549000.0,"AdditionalPaidInCapital_0_Q3_USD":64096000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-48187000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":8946000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":582000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-753000.0,"AccountsReceivableNetCurrent_0_Q3_USD":1667000.0,"AccountsPayableTradeCurrent_0_Q3_USD":1042000.0,"AssetsCurrent_0_Q3_USD":126536000.0,"InvestmentIncomeInterest_1_Q3_USD":27000.0,"DebtSecuritiesAvailableForSaleUnrealizedGainLoss_1_Q3_USD":-31000.0,"DebtSecuritiesRealizedGainLoss_1_Q3_USD":0.0,"InterestExpense_1_Q3_USD":762000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":67000.0,"IncreaseDecreaseInOtherOperatingLiabilities_3_Q3_USD":-243000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":355000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":585000.0,"IncomeLossFromEquityMethodInvestments_3_Q3_USD":0.0,"IncomeLossFromEquityMethodInvestments_1_Q3_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-54926000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-19158000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":12438000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":4146000.0,"GainLossOnSaleOfEquityInvestments_3_Q3_USD":0.0,"DebtSecuritiesAvailableForSaleUnrealizedGainLoss_3_Q3_USD":-16000.0,"ForeignCurrencyTransactionGainLossUnrealized_3_Q3_USD":0.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q3_USD":-15000.0,"EquityMethodInvestments_0_Q3_USD":0.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":0.0,"EarningsPerShareDiluted_3_Q3_USD":-0.68,"EarningsPerShareDiluted_1_Q3_USD":-0.24,"EarningsPerShareBasic_3_Q3_USD":-0.68,"EarningsPerShareBasic_1_Q3_USD":-0.24,"DividendsPreferredStockCash_3_Q3_USD":11565000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":1326000.0,"Depreciation_3_Q3_USD":1326000.0,"Depreciation_1_Q3_USD":447000.0,"DebtSecuritiesRealizedGainLoss_3_Q3_USD":0.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":0.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":97174253.0,"Ticker":"ABUS","CIK":"1447028","name":"ARBUTUS BIOPHARMA CORP","OfficialName":"Arbutus Biopharma Corporation Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"388180699.0","Country":"Canada","Sector":"nan","Industry":"nan","Market":"NASDAQ","SP500":"nan","filed":"20211104"}]